enGene Therapeutics Inc.
Disclosed SEC business address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
enGene Therapeutics Inc. (ticker ENGNW, CIK 0001980845) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Biological Products, (No Diagnostic Substances) (SIC 2836). Every item is grounded on the cited public source — no figures are fabricated.
Go deeper
This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 5 free company deep views left this month.
Sources
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-04T20:44:38.424976+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-04T20:44:42.380537+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-04T20:44:36.353978+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-04T20:44:40.397650+00:00
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.